BB vs BMRN · P/E 117, rev $549.1M vs P/E 40, rev $2.85B
BlackBerry Ltd (BB) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
BB currently screens at market cap $6.14B and trailing P/E 116.5. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the BB and BMRN stock pages for the full models.
Not investment advice.